Facebook
Twitter
LinkedIn
ForwardRational Opioid Prescribing: New Wisconsin Medical Examining Board Prescribing Guideline
Attention UW/UW Health faculty and staff:
You must log in to see your reduced fee.
This course is approved by the State of Wisconsin Department of Safety & Professional Services
Approval #: MEB-1022.
Provided by
UW Health
University of Wisconsin School of Medicine and Public Health
University of Wisconsin-Madison Interprofessional Continuing Education Partnership (ICEP)
Intended Audience
This activity is intended for physicians, nurses, pharmacists, and other faculty and staff affiliated with the University of Wisconsin School of Medicine and Public Health, and UW Health.
Learning Objectives
- Describe the prevalence and impact of chronic pain
- Explain the differences between acute, cancer and chronic non-cancer pain and their implications
- Appreciate and assess potential risks and harm associated with chronic opioid therapy
- Explain when to initiate or continue opioids for chronic non-cancer pain
- Describe criteria for safe opioid selection, dosing, and duration
- List techniques for therapeutic opioid monitoring, risk reduction, discontinuation and addressing opioid use disorder
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).
The University of Wisconsin–Madison ICEP defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The University of Wisconsin–Madison ICEP does not consider providers of clinical service directly to patients to be commercial interests.
NAME | ROLE | FINANCIAL RELATIONSHIPS DISCLOSURE | DISCUSSION OF UNLABELED/ UNAPPROVED USES OF DRUGS/ DEVICES IN PRESENTATION? |
Alaa Abd-Elsayed, MD, MPH | Planner, Presenter | Axsome, Halyard, Innocoll, Medtronic, SpineLOOP™, Ultimaxx Health (Consultant) | No |
Barbara Anderson, MS | Planner | Bristol-Myers Squibb (Stockholder or Other Ownership Interest Holder) | No |
Robert Ebbe, JD | Planner | No relevant financial relationships to disclose | No |
Sandra Galles, MS, RN, APNP | Planner | No relevant financial relationships to disclose | No |
Jan Haedt, BN, RN | Planner | No relevant financial relationships to disclose | No |
Paul Hutson, PharmD, BCOP | Planner, Presenter | Projections Research, Inc. (Consultant) | No |
Cathy Means, MS | Planner | No relevant financial relationships to disclose | No |
Peggy Riley, MN, MPH, RN | Planner, Presenter | No relevant financial relationships to disclose | No |
Nathan Rudin, MD, MA | Planner, Presenter | No relevant financial relationships to disclose | No |
Nalini Sehgal, MD | Presenter | No relevant financial relationships to disclose | No |
Kristin Shadman, MD | Planner | No relevant financial relationships to disclose | No |
Richard Welnick, MD | Planner | No relevant financial relationships to disclose | No |
Aleksandra Zgierska, MD, PhD | Planner, Presenter | No relevant financial relationships to disclose | No |
In s
upport of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
State of Wisconsin Department of Safety & Professional Services Approval #: MEB-1022.
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 2.00 ANCC contact hours, 2.00 of which are eligible for ANCC pharmacotherapeutic contact hours.
UW Risk Management
The University of Wisconsin Hospital and Clinics (UWHC) certifies Risk Management Education Credit for the current UWHC Medical Staff reappointment period based on participant’s applicable Medical Staff status.
Continuing Education Units
The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for .2 continuing education units (CEUs) or 2 hours.
Available Credit
- 2.00 AMA PRA Category 1 Credit™
- 2.00 ANCC Contact Hours
- 2.00 ANCC Pharmacotherapy Contact Hours
- 2.00 University of Wisconsin–Madison Continuing Education Hours